Nicergoline in the long term treatment of mild or moderate senile dementia. A multicenter double-blind, randomized, placebo-controlled trial

By Nicergoline Dementia Long Term Study Italian Group   Battaglia A.   Annoni K.   Pamparana F.   De Paolis C.   Bonura M.L.   Stekke W.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 383-383

Elsevier

Access to resources Recommend Favorite

Efficacy of a Non-Hormonal Treatment, BRN-01, on Menopausal Hot Flashes: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

By Colau Jean-Claude  

Drugs in R&D, Vol. 12, Iss. 3, 2012-09 ,pp. : 107-119

Adis International

Access to resources Recommend Favorite

Rationale and Design of a Randomized, Double-Blind, Placebo Controlled Multicenter Trial to Study Efficacy, Security, and Long Term Effects of Intermittent Repeated Levosimendan Administration in Patients with Advanced Heart Failure: LAICA study

By García-González Martín   Mora-Martín Manuel   López-Fernández Silvia   López-Díaz Javier   Martínez-Sellés Manuel   Romero-García José   Cordero Marco   Lara-Padrón Antonio   Marrero-Rodríguez Francisco   Mar García-Saiz M.   Aldea-Perona Ana  

Cardiovascular Drugs and Therapy, Vol. 27, Iss. 6, 2013-12 ,pp. : 573-579

Springer Publishing Company

Access to resources Recommend Favorite

Optimal Dosing of Galantamine in Patients with Mild or Moderate Alzheimer's Disease: Post Hoc Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial

By Aronson Stephen  

Drugs & Aging, Vol. 26, Iss. 3, 2009-01 ,pp. : 231-239

Adis International

Access to resources Recommend Favorite

Effect of twelve-months therapy with oral ambroxol in preventing exacerbations in patients with COPD. Double-blind, randomized, multicenter, placebo-controlled study (the AMETHIST Trial)

By Malerba M.   Ponticiello A.   Radaeli A.   Bensi G.   Grassi V.  

Pulmonary Pharmacology & Therapeutics, Vol. 17, Iss. 1, 2004-02 ,pp. : 27-34

Elsevier

Access to resources Recommend Favorite